Glutamate-N-methyl-D-aspartate receptor modulation and minocycline for the treatment of patients with schizophrenia: an update

Overview of attention for article published in Brazilian Journal of Medical and Biological Research, November 2009

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter: 3 X users
patent: 1 patent

facebook: 1 Facebook page

Citations

dimensions_citation: 48 Dimensions

Readers on

mendeley: 74 Mendeley

Summary X Patents Facebook Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 425 followers.

RT @ueafam: 統合失調症患者の治療のためのグルタミン酸NMDA受容体調節とミノサイクリン：最新情報 2009 脳内での #ミノサイクリンの作用の正確な機序は未だ不明だが、#NMDA拮抗薬の #神経毒性を遮断し、#NMDAシグナル伝達経路に異なる効果を及ぼす可能…

06 Dec 2023

Reply Repost Favourite

統合失調症患者の治療のためのグルタミン酸NMDA受容体調節とミノサイクリン：最新情報 2009 脳内での #ミノサイクリンの作用の正確な機序は未だ不明だが、#NMDA拮抗薬の #神経毒性を遮断し、#NMDAシグナル伝達経路に異なる効果を及ぼす可能性を示す証拠がある。 #無料記事 https://t.co/ZBv7Khf9S0

08 Aug 2020

Reply Repost Favourite

Glutamate-N-methyl-D-aspartate receptor modulation and minocycline for treatment of patients schizophrenia: http://t.co/nSUQKTu

09 Sep 2011

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.